Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance
- Conditions
- HypertensionIschemic Stroke
- Interventions
- Behavioral: Behavioral intensificationDevice: Bluetooth-equipped sphygmomanometer
- Registration Number
- NCT03024476
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
BOSS-Trial I is a phase 2 clinical trial with the following objectives;
1. to prove the feasibility of a Bluetooth-equipped sphygmomanometer system in real-world clinical practice and wireless connection to the main server;
2. to prove the feasibility of the BP management strategy, including the pre-specified BP range, BP management algorithm, and behavioral; and
3. to gather information for the phase 3 trial including BP variability indices and their potentials as a treatment guidance.
- Detailed Description
* Elevated blood pressure is an established risk factor for recurrent stroke and vascular events in ischemic stroke survivors, but
* Current guideline (JNC VIII) has omitted or only partially covered a number of practical and important issues as follow;
* When and how we measure blood pressure?
* Is it justifiable to apply the same blood pressure threshold for office BP and home BP?
* Should stroke survivors be treated by the same BP goal for non-stroke subjects?
* Is it justifiable to apply the universal BP threshold for different mechanisms of ischemic stroke?
* Is it really about only blood pressure or might it really be "beyond blood pressure?"
* Lifestyle modification should accompany all the pharmacological intervention but is usually in adequate to initiate behavioral changes.
* Frequent BP measurement at home will provide more detailed and reliable information than occasional office BP's.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 67
- Ischemic stroke survivors within 7 days after onset
- ≥19 year-old male or female
- Medically and neurologically stabilized enough to take BP-lowering medication
- Mean systolic blood pressure ≥135 mm Hg during two days between at least 24 hours after onset and randomization (whether BP-lowering medication was prescribed or not)
- Capable of taking oral medication
- Capable of operating a wireless Bluetooth-equipped sphygmomanometer system and being expected to follow required procedures of the clinical trial
- Patients who provided written informed consent
- Pregnant, puerperium ≤30 days or on breastfeeding
- enrolled in other interventional clinical trial
- Being transferred to rehabilitation center or institutionalized
- Being expected to have cerebral artery interventions within 3 months after randomization
- Known allergic reactions to olmesartan, amlodipine or hydrochlorothiazide
- Known severe hepatic disease
- Advanced kidney dysfunction requiring dialysis
- Being unlikely, in the opinion of the investigator, to comply with the clinical trial protocol or being unsuitable for any other reason.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intensive management arm Pharmacological intensification based on olmesartan Description: * Interventions in the intensive management arm consist of 1) behavioral intensification and 2) pharmacological intensification based on olmesartan * Participants will be given a wireless Bluetooth-equipped sphygmomanometer system, which is connected to the main server through the participants' own smartphone. Every blood pressure and heart rate measured will be encrypted and stored in the main server (Identical for both intervention and control groups). * Regarding behavioral intensification, an automated texting and call for breakthrough visit will be sent from the main server to encourage regular measurements of BP and maintain a desirable goad of BP. * Regarding pharmacological intensification, a specific algorithm for BP-lowering medication prescription will be provided to the responsible physicians by the steering committee. Intensive management arm Bluetooth-equipped sphygmomanometer Description: * Interventions in the intensive management arm consist of 1) behavioral intensification and 2) pharmacological intensification based on olmesartan * Participants will be given a wireless Bluetooth-equipped sphygmomanometer system, which is connected to the main server through the participants' own smartphone. Every blood pressure and heart rate measured will be encrypted and stored in the main server (Identical for both intervention and control groups). * Regarding behavioral intensification, an automated texting and call for breakthrough visit will be sent from the main server to encourage regular measurements of BP and maintain a desirable goad of BP. * Regarding pharmacological intensification, a specific algorithm for BP-lowering medication prescription will be provided to the responsible physicians by the steering committee. Intensive management arm Behavioral intensification Description: * Interventions in the intensive management arm consist of 1) behavioral intensification and 2) pharmacological intensification based on olmesartan * Participants will be given a wireless Bluetooth-equipped sphygmomanometer system, which is connected to the main server through the participants' own smartphone. Every blood pressure and heart rate measured will be encrypted and stored in the main server (Identical for both intervention and control groups). * Regarding behavioral intensification, an automated texting and call for breakthrough visit will be sent from the main server to encourage regular measurements of BP and maintain a desirable goad of BP. * Regarding pharmacological intensification, a specific algorithm for BP-lowering medication prescription will be provided to the responsible physicians by the steering committee. Control arm Bluetooth-equipped sphygmomanometer Description: * Other than a bluetooth-equipped sphygmomanometer, standard managements abiding by the most current guideline will be provided from the responsible physicians. * Participants will be given a Bluetooth-equipped sphygmomanometer, which is connected to the main server through the participants' own smartphone. Every blood pressure and heart rate measured will be encrypted and stored in the main server (Identical for both intervention and control groups).
- Primary Outcome Measures
Name Time Method Rate of patients who responded to the calls for breakthrough visit At 3 months after randomization ratio of subjects response over the breakthrough visit calls
Retention of included participants At 3 months after randomization Ratio of completed subject over randomized subjects in each group
Control of blood pressure At 3 months after randomization ratio of subjects with well-controlled BP in each group
Recruitment time to prespecified number of subjects At 3 months after randomization Difference in days between recruitment of the first subject and last subject
Frequencies of calls for breakthrough visit At 3 months after randomization Mean and standard deviation of breakthrough visits per each patient in the intensive management group
- Secondary Outcome Measures
Name Time Method Weighted hit score of BP At 3 months after randomization When two consecutive hits crossed over or below the margin of desirable BP, give 2x weight. Final score will be generated by dividing by total number of measurements
Hypotensive events Until 3 months after randomization Complaint of dizzy spells, falls or low-BP related events by patients
Vascular events At 3 months after randomization Recurrent vascular events including recurrent stroke, myocardial infarction or vascular death
Frequency of out-of-range measurement At 3 months after randomization Frequency of BP measurements out of the desirable BP range in a week
Trial Locations
- Locations (3)
Seoul National University Bundang Hospital
🇰🇷Seongnam, Gyeonggi, Korea, Republic of
Nowon Eulji Medical Center, Eulji University
🇰🇷Seoul, Korea, Republic of
Seoul Medical Center
🇰🇷Seoul, Korea, Republic of